Skip to main content
Log in

A Test of the reliability and validity of a diabetes specific quality of life scale in a Nigerian hospital

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

The purpose of this study was to test the reliability of the Well-being and Diabetes Treatment Satisfaction Questionnaires among clinic patients with type 2 diabetes as well as determine the clinical correlates of these measures. A cross-sectional survey was conducted using the Well-being Questionnaire and the Diabetes Treatment Satisfaction Questionnaire. Other demographic and clinical indices of age, sex, body mass index, disease duration and blood glucose levels were also recorded. 83 responses were analysed. Subjects were aged between 25 and 75 years, mean 55.5 ± 11.1 years. 50.6% were males while 49.4% were females. Mean diabetes duration was 4.9 ± 6.5 years. 67 (80.7%) were receiving oral agents and dietary modification while 16 (19.3%) were on insulin therapy. The internal consistency for responses to the well-being subscales and treatment satisfaction scale produced satisfactory α coefficients ranging from 0.73 to 0.88 and 0.74 respectively. Inter-item correlations were ranged between 0.19 and 0.45 for depression subscale; 0.22–0.78 for anxiety subscale; 0.33–0.58 for energy subscale; 0.33–0.79 for positive well-being subscale; and −0.22 to 0.79 for the treatment satisfaction scale. Item-total correlations ranged between 0.39 and 0.87 across the two scales: well-being (0.59–0.87) and treatment satisfaction (0.39–0.78). Mean scale scores were similar in both insulin and oral hypoglycaemic drug treated patients. Positive well-being was higher in males 13.4 ± 4.1 vs. 11.5 ± 4.3 in females p= 0.04. None of the well-being subscale scores, or treatment satisfaction correlated with age, disease duration, body mass index or glycaemic control. The well-being and treatment satisfaction scales are reliable instruments for the measurement of diabetes specific quality of life and treatment satisfaction in Nigerians although they were originally designed and developed among a UK population. It is hoped that our data would provide the basis for future comparisons and improving diabetes care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. The Expert Committee on Non-communicable Disease. Non-Communicable Disease in Nigeria. Final report of a national survey, Federal Ministry of Health, Lagos 1997.

  2. Ohwovoriole AE, Kuti JA, Kabiawu SIO. Casual blood glucose levels and prevalence of undiscovered diabetes mellitus in Lagos metropolis Nigerians. Diabet Res Clin Pract 1988; 4: 153–158.

    Google Scholar 

  3. Famuyiwa OO, Edozien EM, Ukoli CO. Social, cultural and economic factors in the management of diabetes mellitus in Nigeria. Afr J Med med Sci 1985; 14: 145–154.

    PubMed  Google Scholar 

  4. Olanrewaju SO, Johnson TO. Diabetes mellitus-its sociopsychological and socio-economic complications-experience in a densely populated African city. Excerpta Medica (abstr) Amsterdam, International Congress Series 1982; 577: 76.

    Google Scholar 

  5. Fabiyi AK, Kolawole BA, Adefehinti O, Ikem RT. The impact of knowledge, attitude, practice, and beliefs of type 2 Nigerian diabetic patients on drug compliance. Diabet Int 2002; 12: 15–17.

    Google Scholar 

  6. Blonde L. Management of type 2 diabetes: Update on new pharmacological options. Manag Care 2000; 9: 11–17.

    Google Scholar 

  7. Owens DR, Zinman B, Billi GB. Insulins today and beyond. Lancet 2001; 358: 739–746.

    Article  PubMed  Google Scholar 

  8. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986.

    Google Scholar 

  9. Bradley C, Gamsu DS. Guidelines for encouraging psychological well-being: Report of a working group of the World Health Organisation Regional Office for Europe and International Diabetes Federation European Region St Vincent Declaration Action Programme for Diabetes. Diabet Med 1994; 21: 510–516.

    Google Scholar 

  10. Petterson T, Lee P, Hollis S, Young B, Newton P, Dornan T. Well-being and Treatment Satisfaction in older people with diabetes. Diabet Care 1998; 21: 930–935.

    Google Scholar 

  11. Bradley C. The Well-being Questionnaire. In: Bradley C (ed.), Handbook of Psychology and Diabetes. Chur Switzerland, Harwood 1994a; 89–109.

  12. Bradley C, Lewis KS. Measures of psychological well-being and treatment satisfaction developed from responses of people with tablet treated diabetes. Diabet Med 1990;7: 445–451.

    PubMed  Google Scholar 

  13. Bradley C. Diabetes Treatment Satisfaction Questionnaire. In: Bradley C (ed.),Handbook of Psychology and Diabetes. Chur Switzerland, Harwood 1994b; 111–132.

  14. Williams DRR, Home PD, and Members of a Working Group of the Research Unit of the Royal College of Physicians and British Diabetic Association: A proposal for continuing audit of diabetes services. Diabet Med 1992; 9: 759–764.

    PubMed  Google Scholar 

  15. Larson D, Lager I, Nilson PM. Socio-economic characteristics and quality of life in diabetes mellitus-relation to metabolic control. Scand J Public Health 1999; 27: 101–105.

    Article  PubMed  Google Scholar 

  16. Rubin RR, Peyrot M. Psychosocial problems and interventions in diabetes: A review of the literature. Diabet Care1992; 15: 1640–1657.

    Google Scholar 

  17. Glasgow RE, Osteen VL. Evaluating diabetes education: Are we measuring the most important outcomes? Diabet Care 1992; 15: 1423–1432.

    Google Scholar 

  18. Brown GC, Brown MM, Sharma S, Brown H, Gozum M, Denton P. Quality of life associated with diabetes mellitus in an adult population. J Diabet Complicat2000; 14: 18–24.

    Article  Google Scholar 

  19. Wredling R, Stalhammar J, Adamson U, Berne C, Larsson Y, Ostman J. Well-being and treatment satisfaction in adults with diabetes: A Swedish population-based study. Qual Life Res 1995; 45: 515–522.

    Google Scholar 

  20. Anderson RM, Fitzgerald JT, Wisdom K, Davis WK, Hiss RG. A comparison of global versus disease-specific qualityof-life measures in patients with NIDDM. Diabet Care 1997; 20: 299–305.

    Google Scholar 

  21. Hanestad BR, Hornquist JO, Albrektsen G. Self-assessed quality of life and metabolic control in persons with insulin dependent diabetes mellitus (IDDM). Scand J Soc Med 1991; 19: 57–65.

    PubMed  Google Scholar 

  22. Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycaemic control in patients with type 2 diabetes. JAMA 1998; 280: 1490–1496.

    PubMed  Google Scholar 

  23. The Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on qualityof-life outcomes in the Diabetes Control and Complications Trial. Diabet Care 1996; 19: 195–203.

    Google Scholar 

  24. Weinberger M, Kirkman MS, Samsa GP, et al. The relationship between glycaemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus. Med Care 1994; 32: 1173–1181.

    PubMed  Google Scholar 

  25. Klein R, Klein BE. Relation of glycaemic control to diabetic complications and health outcomes. Diabetes Care 1998; 21 Suppl 3: C39–C43.

    PubMed  Google Scholar 

  26. de Souza TT, Santini L, Wada SA, Vasco CF, Kimura M. The quality of life of diabetics. Rev Esc Enferm USP 1997; 31: 150–164.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kolawole, B., Abodunde, O., Ikem, R. et al. A Test of the reliability and validity of a diabetes specific quality of life scale in a Nigerian hospital. Qual Life Res 13, 1287–1295 (2004). https://doi.org/10.1023/B:QURE.0000037483.85545.5f

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:QURE.0000037483.85545.5f

Navigation